SCHEMBL6687250

SCHEMBL6687250

O=C1CC(C=Cc2ccccc2[N+](=O)[O-])N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
SOS1 Q07889 1/20 0.46
TDP2 O95551 1/20 0.45
CASP7 P55210 1/20 0.45
CASP9 P55211 1/20 0.45
CASP6 P55212 1/20 0.45
CASP8 Q14790 1/20 0.45
MAOB P27338 1/20 0.44
XDH P47989 1/20 0.44
ALDH1A1 P00352 5/20 0.44
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6687245 1.00 MAPT (0.48) MAPTSOS1TDP2CASP7CASP9
SCHEMBL6687242 1.00 MAPT (0.48) MAPTSOS1TDP2CASP7CASP9
SCHEMBL6976986 0.81 ALDH1A1 (0.50) MAPTSOS1TDP2CASP7CASP9
SCHEMBL6976988 0.81 ALDH1A1 (0.50) MAPTSOS1TDP2CASP7CASP9
SCHEMBL6976996 0.81 ALDH1A1 (0.50) MAPTSOS1TDP2CASP7CASP9
SCHEMBL3131670 0.76 MAPT (0.54) MAPTSOS1MAOBALDH1A1NPC1
SCHEMBL3131663 0.76 MAPT (0.54) MAPTSOS1MAOBALDH1A1NPC1
SCHEMBL30810472 0.76 MAPT (0.54) MAPTSOS1MAOBALDH1A1NPC1
SCHEMBL11332190 0.76 ALDH1A1 (0.50) MAPTSOS1MAOBALDH1A1NPC1
SCHEMBL11332188 0.76 ALDH1A1 (0.50) MAPTSOS1MAOBALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004089362-A1 2-CYANOPYRROLES AND THEIR ANALOGUES AS DDP-IV INHIBITORS NOVO NORDISK A/S (DK) 2004-10-21 WO disclosed